Arcturus Therapeutics Holdings, Inc. (ARCT)

7.25 -0.21 (-2.82%) USD  |  NASDAQ  |  Dec 15, 16:00
7.22 -0.03 (-0.41%) After-Hours: 06:08
More

Arcturus Therapeutics Holdings Total Long Term Debt (Quarterly): 21.86M for Sept. 30, 2025

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ARCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. 7.282M
Novavax, Inc. 251.14M
Sangamo Therapeutics, Inc. 25.42M
Capricor Therapeutics, Inc. 17.80M
AIM ImmunoTech, Inc. 2.106M